EUCTR2009-016966-97-DE进行中（未招募）不适用
Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized, Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients with Cold Agglutinin Disease Using Eculizumab - DECADE Trial
niversitätsklinikum Essen0 个研究点开始时间: 2010年2月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis of CAD defined by the combination of chronic hemolysis, cold agglutinin titer (IgM or IgA) >64 at 4°C, positive direct antiglobulin test (DAT) when performed with polyspecific antiserum, negative (or only weakly positive) anti-IgG, and strongly positive with anti-C3d.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •An active aggressive lymphoma requiring therapy or an active non-lymphatic malignant disease other than basal cell carcinoma or CIS of the cervix.
研究者
相似试验
进行中（未招募）
1 期
Therapy for chronic cold agglutinin disease: A prospective,non-randomized international multicenter trial on the safetyand efficacy of bendamustine and rituximab combinationtherapy.EUCTR2011-004835-30-DKDepartment of Medicine, Haugesund Hospital50
进行中（未招募）
1 期
Therapy for chronic cold agglutinin disease: A prospective,non-randomized international multicenter trial on the safetyand efficacy of bendamustine and rituximab combinationtherapy.Primary chronic cold agglutinin disease requiringtreatmentEUCTR2011-004835-30-FIDepartment of Medicine, Haugesund Hospital45
进行中（未招募）
1 期
Therapy for chronic cold agglutinin disease: A prospective,non-randomized international multicenter trial on the safetyand efficacy of bendamustine and rituximab combinationtherapy.EUCTR2011-004835-30-NODepartment of Medicine, Haugesund Hospital45
已完成
1 期
A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin DiseaseAutoimmune Haemolytic AnaemiaNCT04269551Bioverativ, a Sanofi company12
已完成
2 期
Bendamustine and Rituximab Combination Therapy for Cold Agglutinin DiseaseCold Agglutinin DiseaseAutoimmune Hemolytic AnemiaNCT02689986Helse Fonna43